Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year

Filters applied: . Clear all
Page 1
Hypereosinophilia and Hypereosinophilic Syndromes: First Findings From a Nationwide Multicenter Cohort.
Lefèvre G, Bleuse S, Puyade M, Moulis G, Néel A, Abisror N, Baudet A, Bonnotte B, Dion J, Dossier A, Grall M, Lifermann F, Limal N, Lioger B, Machelart I, Mohr C, Outh R, Queyrel-Moranne V, Slama B, Tréfond L, Abou Chahla W, Ackerman F, Belfeki N, Berezne A, Blade JS, Bouderbala MA, Chebrek S, Cottin V, De Almeida S, De Masson A, Dezoteux F, Goulenok T, Jachiet V, Jouvray M, Latu I, Ledoult E, Leurs A, Lugosi M, Martin M, Melboucy-Belkhir S, Morati-Hafsaoui C, Quemeneur T, Rohmer J, Roy-Peaud F, Sanges S, Schleinitz N, Staumont-Salle D, Taillé C, Terriou L, Tieulie N, Koenga JDE, Schwarb L, Panel K, Kahn JE, Groh M; COHESion study group. Lefèvre G, et al. Allergy. 2025 Apr;80(4):1100-1110. doi: 10.1111/all.16463. Epub 2025 Jan 5. Allergy. 2025. PMID: 39757773
Development and validation of the FIP-Score for the screening of FIP1L1::PDGFRA-associated hypereosinophilic syndrome.
Stammler R, Vallée A, Rohmer J, Grardel N, Abisror N, Chahla WA, Ackermann F, Baudet A, Belfeki N, Ben Abdelali R, Bidet A, Bladé JS, Bleuse S, Bonnotte B, Bouderbala MA, Cayuela JM, Chebrek S, Dion J, Dossier A, Duployez N, Faguer S, Flandrin-Gresta P, Galicier L, Godon C, Grall M, Jachiet V, Jouvray M, Latu I, Ledoult E, Lengline E, Leurs A, Lhermitte L, Lifermann F, Limal N, Lioger B, Lugosi M, Machelart I, Martin M, Martis N, Mauvieux L, Melboucy-Belkhir S, Mohr C, Moulis G, Mozicconacci MJ, Naguib D, Néel A, Nicolini FE, Outh R, Panel K, Preudhomme C, Puyade M, Quemeneur T, Moranne VQ, Rey J, Rousselot P, Schleinitz N, Slama B, Staumont-Salle D, Taillé C, Terriou L, Tréfond L, Viallard JF, Kahn JE, Lefèvre G, Groh M; COHESion, CEREO and GBMHM groups. Stammler R, et al. J Allergy Clin Immunol Pract. 2025 Sep 22:S2213-2198(25)00903-1. doi: 10.1016/j.jaip.2025.09.009. Online ahead of print. J Allergy Clin Immunol Pract. 2025. PMID: 40992688